Related Experiment Video
Updated: Mar 18, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Development of a nomogram for predicting 2-year native liver survival in biliary atresia using dynamic liver function
Bingliang Li1,2, Hongxia Ren1
1Department of Neonatal Surgery, Shanxi Medical University Affiliated Children's Hospital, Taiyuan, China.
A new nomogram accurately predicts 2-year native liver survival (NLS) in children with biliary atresia (BA) after Kasai surgery. This tool aids clinicians in making personalized treatment decisions and optimizing early interventions for high-risk pediatric patients.
Area of Science:
- Pediatric Hepatology
- Surgical Gastroenterology
- Biostatistics
Background:
- Biliary atresia (BA) is a leading cause of pediatric liver disease requiring surgical intervention.
- The Kasai procedure is a common surgical treatment for BA, but outcomes vary significantly.
- Predicting long-term native liver survival (NLS) is crucial for guiding management and parental counseling.
Purpose of the Study:
- To develop and validate a predictive nomogram for 2-year NLS in children with BA post-Kasai surgery.
- To integrate dynamic liver function indexes into a robust prognostic model.
- To provide clinicians with a tool for individualized treatment decisions and early intervention strategies.
Main Methods:
- A cohort of 134 children with type III BA was analyzed.
- Logistic regression identified predictors of 2-year NLS, including age at surgery, jaundice clearance, fibrosis stage, and postoperative liver function tests (GGT, ALB, APRI).
- A nomogram was constructed and validated using internal bootstrap resampling and a training-test split, with performance assessed by AUC and calibration curves.
Main Results:
- Key predictors of NLS included advanced liver fibrosis (F4), high 3-month APRI, older age at surgery, elevated 3-month GGT, lower 3-month ALB, and failure of jaundice clearance.
- The nomogram demonstrated strong predictive performance with an AUC of 0.872 in the training set and 0.971 in the test set.
- The model showed consistent accuracy across different age subgroups.
Conclusions:
- A validated nomogram effectively predicts 2-year NLS in children with BA after Kasai surgery.
- The model integrates readily available clinical and biochemical data for prognostic assessment.
- This tool supports personalized management strategies and timely interventions for high-risk pediatric BA patients, especially in resource-limited settings.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

